Results 71 to 80 of about 1,218 (152)

Characterization and comparison of sodium-glucose cotransporter 2 inhibitors: Part 2. Antidiabetic effects in type 2 diabetic mice

Journal of Pharmacological Sciences, 2016
Previously we investigated the pharmacokinetic, pharmacodynamic, and pharmacologic properties of all six sodium-glucose cotransporter (SGLT) 2 inhibitors commercially available in Japan using normal and diabetic mice.
Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki   +4 more
doaj   +1 more source

Nocturia and SGLT2 inhibitors: A review of pathophysiology, clinical evidence, and therapeutic implications

Continence
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are widely used in patients with diabetes, heart failure, and chronic kidney disease, all of whom are at elevated risk for nocturia.
Matthew Antonellis, Robert Adler, Michael Kozlov, Jason Lazar, Jeffrey P. Weiss   +4 more
doaj   +1 more source

Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis

Journal of Diabetes Research
Background. Beyond glycemic control, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have been proposed to reduce the risk of cardiovascular events.
Abolfazl Akbari, Shiva Hadizadeh, Leida Heidary   +2 more
doaj   +1 more source

Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors. [PDF]

Acta Derm Venereol
Ikeda A, Tani N, Ishii N, Koga H, Yoshida Y.   +4 more
europepmc   +1 more source

Progranulin Deficiency Improves Metabolic Stress Yet Falls Short of Sodium-Glucose Cotransporter-2 Inhibition in Autophagy-Linked Renal Protection. [PDF]

Endocrinol Metab (Seoul)
Im SS.
europepmc   +1 more source

Pharmacological research of a novel selective SGLT2 inhibitor, tofogliflozin

Pharmacological research of a novel selective SGLT2 inhibitor, tofogliflozin
学位の種別: 論文博士 審査委員会委員 : (主査)東京大学教授 九郎丸 正道, 東京大学教授 中山 裕之, 東京大学教授 久和 茂, 東京大学准教授 堀 正敏, 東京大学准教授 金井 ...
openaire  

Effect of Tofogliflozin on Skeletal Muscle Mitochondrial Function in Male Diabetic Mice With Muscle Atrophy. [PDF]

J Endocr Soc
Kishida C, Murakoshi M, Sakuma H, Shibata T, Suzuki Y, Gohda T.   +5 more
europepmc   +1 more source

Effect of tofogliflozin on obesity-related health problems in patients with type 2 diabetes and overweight or obesity-a post-hoc sub-analysis of the UTOPIA study. [PDF]

Diabetol Int
Katakami N, Mita T, Masuda T, Sato Y, Watada H, Shimomura I.   +5 more
europepmc   +1 more source

Trends in sodium-glucose transport protein 2 inhibitor prescriptions: application of the ATC/DDD system to NDB open data. [PDF]

Diabetol Int
Miyake T, Hashimoto M, Kadowaki D.
europepmc   +1 more source

Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial. [PDF]

Diabetes Ther
Kimura K, Takagi Y, Harada M, Ueda S, Minamisawa M, Sonoda K, Oiwa A, Yazaki Y, Sakurai S, Tomita T, Kaneko K, Yamamoto K, Takama N, Momose S, Inobe Y, Nogi K, Koshikawa M, Misawa T, Kasai T, Tsutsui H, Watanabe N, Yamazaki K, Miyamoto T, Midorikawa T, Usui T, Saigusa T, Motoki H, Saito Y, Kamijo Y, Komatsu M, Kuwahara K.   +30 more
europepmc   +1 more source